Clareon™ PanOptix™ Toric Trifocal Hydrophobic IOL
- Risk class
- III
- Product type
- Invasive
- Brand name
- Clareon™
- Commercial name
- Intraocular lenses
- Sterilization method
- ETHYLENE OXIDE
- Analysis ID
- 5c6c3ecfb1475e2200741c07ca96a17f
- Registration date
- September 17, 2021
- Expiration date
- September 17, 2026
- Creation date
- September 17, 2021
- City
- CORK IRELAND
- Country
- IRELAND
- Address
- CORK BUSINESS & TECHNOLOGY PARK, MODEL FARM RD, CORK IRELAND
- Name
- ALCON LABORATORIES, INC.
- Country
- UNITED STATES
- Address
- AVENIDA AMAZONAS N37-29 AND NATIONAL UNION OF JOURNALISTS. EUROCENTER BUILDING. FLOOR 6
- Phone
- 23933020
THE CLAREON™ PANOPTIX™ TORIC TRIFOCAL LIO IS DESIGNED TO BE IMPLANTED IN THE CAPSULAR SAC OF THE POSTERIOR CHAMBER OF THE EYE, REPLACING THE HUMAN LENS. THIS POSITION OF THE LENS ALLOWS THE LIO TO ACT AS A MEANS OF REFRACTION IN THE CORRECTION OF APHAKIA AND PRE-EXISTING ASTIGMATISM.
Access comprehensive regulatory information for Clareon™ PanOptix™ Toric Trifocal Hydrophobic IOL in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID 5c6c3ecfb1475e2200741c07ca96a17f and manufactured by ALCON LABORATORIES IRELAND LTD.. The device was registered on September 17, 2021.
This page provides complete registration details including product type (Invasive), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.